US Patent 9212225 Bispecific CD33 and CD3 binding proteins
Patent 9212225 was granted and assigned to Amphivena Therapeutics on December, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 9, 2015
Date of Patent
December 15, 2015
Patent Applicant
Patent Application Number
14642497
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9212225 Bispecific CD33 and CD3 binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.